- Lobbying
- Lobbying by Roche Diagnostics
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Marsha Simon | Staff, Senate HELP Committee Sen. Appropriations Senate Appropriations |
Kathleen Llewellyn-Butts | Staff Assistant, Senate Budget Committee |
Melanie Morris | n/a |
Kristin Serfass | n/a |
Karen Late | n/a |
Rebecca Wolff | n/a |
Jamison Scott | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
Type of Issue
Amendment
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Agency for International Development (USAID)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Agency for International Development (USAID)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Agency for International Development (USAID)
Type of Issue
Q4 Report
Amendment
Q3 Report
Q2 Report
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Q1 Report
Registration
Issue(s) they said they’d lobby about: Supporting Federal efforts for diabetes care in less developed countries.
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate